|
|
||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 245, Issue 1 64-G71, Copyright © 1983 by American Physiological Society
ARTICLES |
B. Wallmark, B. M. Jaresten, H. Larsson, B. Ryberg, A. Brandstrom and E. Fellenius
The action of the substituted benzimidazole omeprazole (H 168/68) was studied in three different in vitro preparations: the isolated guinea pig gastric mucosa, isolated intact and permeable rabbit gastric glands, and hog fundic microsomal membrane vesicles containing H+-K+-ATPase. The effects of omeprazole were compared with those of cimetidine and thiocyanate (SCN-). Under all the conditions studied, cimetidine only counteracted histamine-induced acid secretion, consonant with its H2-receptor antagonism. In contrast, omeprazole and SCN- were found not only to inhibit histamine-induced secretion but also basal acid formation and acid formation induced by dibutyryl cAMP and a high cell medium concentration of K+. Moreover, acid production induced by ATP in permeable gastric glands was antagonized by omeprazole and SCN-, whereas cimetidine was without effect. The interaction pattern of omeprazole and SCN- was differentiated by studies using the weak base antipyrine in the isolated mucosal preparation, where it was found that antipyrine could reverse the inhibition induced by SCN- but not that of omeprazole. Furthermore, omeprazole was found to inhibit the isolated H+-K+-ATPase, whereas cimetidine or SCN- was without effect. In the isolated mucosal preparation omeprazole caused an increase in K+ secretion rates in parallel with the inhibition of acid formation. This was in contrast to what was observed for cimetidine and SCN-, which exhibited no such increased K+ secretion. The results obtained from intact mucosa and isolated glands are in agreement with the ability of omeprazole to inhibit the isolated H+-K+-ATPase and thus provide evidence of a novel mechanism of action for this inhibitor.
This article has been cited by other articles:
![]() |
T. Shibata, H. Hibino, K. Doi, T. Suzuki, Y. Hisa, and Y. Kurachi Gastric type H+,K+-ATPase in the cochlear lateral wall is critically involved in formation of the endocochlear potential Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1038 - C1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Äbelö, U. G. Eriksson, M. O. Karlsson, H. Larsson, and J. Gabrielsson A Turnover Model of Irreversible Inhibition of Gastric Acid Secretion by Omeprazole in the Dog J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 662 - 669. [Abstract] [Full Text] |
||||
![]() |
I. Puscas, M. Coltau, M. Baican, and G. Domuta Omeprazole Has a Dual Mechanism of Action: It Inhibits Both H+K+ATPase and Gastric Mucosa Carbonic Anhydrase Enzyme in Humans (In Vitro and In Vivo Experiments) J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 530 - 534. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |